Author Correction: Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.

Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
30 06 2020
Historique:
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 2 7 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41467-020-17273-7 PMID: 32606313 PMC: PMC7327042
pubmed: 32606313
doi: 10.1038/s41467-020-17273-7
pii: 10.1038/s41467-020-17273-7
pmc: PMC7327042
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

3300

Subventions

Organisme : British Heart Foundation
ID : PG/16/4/31849
Pays : United Kingdom

Commentaires et corrections

Type : ErratumFor

Auteurs

Hebah A Sindi (HA)

National Heart and Lung Institute, Imperial College London, London, UK.
University of Jeddah, College of Science, Department of Biology, Jeddah, Saudi Arabia.

Giusy Russomanno (G)

National Heart and Lung Institute, Imperial College London, London, UK.
ORCID: 0000-0002-3378-5524

Sandro Satta (S)

National Heart and Lung Institute, Imperial College London, London, UK.

Vahitha B Abdul-Salam (VB)

National Heart and Lung Institute, Imperial College London, London, UK.

Kyeong Beom Jo (KB)

National Heart and Lung Institute, Imperial College London, London, UK.
ORCID: 0000-0001-6254-2030

Basma Qazi-Chaudhry (B)

Department of Physics, King's College London UK, London, UK.
ORCID: 0000-0001-5588-0947

Alexander J Ainscough (AJ)

National Heart and Lung Institute, Imperial College London, London, UK.

Robert Szulcek (R)

Amsterdam UMC, VU University Medical Center, Department of Pulmonary Diseases, Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands.
ORCID: 0000-0003-0450-7338

Harm Jan Bogaard (HJ)

Amsterdam UMC, VU University Medical Center, Department of Pulmonary Diseases, Amsterdam Cardiovascular Sciences (ACS), Amsterdam, The Netherlands.

Claire C Morgan (CC)

National Heart and Lung Institute, Imperial College London, London, UK.
ORCID: 0000-0002-8191-3738

Soni S Pullamsetti (SS)

Max Planck Institute for Heart and Lung Research, Department of Lung Development and Remodeling, Member of the German Center for Lung Research (DZL), Bad Nauheim, Germany.
Department of Internal MedicineUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the DZL, Justus Liebig University, Giessen, Germany.
ORCID: 0000-0003-0440-8831

Mai M Alzaydi (MM)

National Heart and Lung Institute, Imperial College London, London, UK.
National Center for Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.

Christopher J Rhodes (CJ)

National Heart and Lung Institute, Imperial College London, London, UK.
ORCID: 0000-0002-4962-3204

Roberto Piva (R)

Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
ORCID: 0000-0002-2273-3470

Christina A Eichstaedt (CA)

Centre for Pulmonary Hypertension, Thoraxclinic, Institute for Human Genetics, University of Heidelberg, Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.
Laboratory of Molecular Genetic Diagnostics, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
ORCID: 0000-0001-7288-8297

Ekkehard Grünig (E)

Centre for Pulmonary Hypertension, Thoraxclinic, Institute for Human Genetics, University of Heidelberg, Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.

Martin R Wilkins (MR)

National Heart and Lung Institute, Imperial College London, London, UK.
ORCID: 0000-0003-3926-1171

Beata Wojciak-Stothard (B)

National Heart and Lung Institute, Imperial College London, London, UK. b.wojciak-stothard@imperial.ac.uk.
ORCID: 0000-0002-6607-7372

Classifications MeSH